Coccidioidomycosis, one of the major systemic mycoses in the Western hemisphere, is endemic in the southwestern United States from Texas to California. Inhalation of airborne arthroconidia (arthrospores) results in a primary respiratory infection. Almost 100,000 people are infected this way each year (16) . Although less than half of these infections produce symptoms, those that do account for much morbidity and mortality (7) . Mortality is essentially limited to those unfortunate people who suffer extrapulmonary spread of infection. Although there is no evidence that the incidence of infection, or even the incidence of symptomatic infection, is genetically influenced, there is very good epidemiological evidence that the risk of dissemination after infection is, in large part, genetically controlled (16) . Dissemination occurs in approximately 1% of white men who are newly infected. However, the rate of dissemination in black men and women is 10 to 20 times higher (11) . Data from the military, collected under conditions in which the degree of exposure was equivalent, indicate that the rate of dissemination in blacks is 10 times that in whites (20) . Filipinos (and probably other Asians) seem to be even more susceptible. Thus, although coccidioidomycosis resembles the other systemic mycoses in affecting previously healthy people, it is unique in that the risk of serious infection is strongly influenced by the racial (genetic) background of the host.
Since mice are susceptible to infection with Coccidioides immitis (2) and a great deal is known about the mouse genome, we chose to use a murine model of coccidioidomycosis to try to elucidate the genetics of resistance. We reasoned that by studying experimental coccidioidomycosis in different strains of inbred mice, we might detect genetically determined differences in resistance that could provide insights into the mechanisms of resistance to C. immitis. A similar approach has been used to study genetic resistance to facultative and obligate intracellular pathogens (3, 5) . In this paper, we report that inbred mouse strains vary as much as 1,000-fold in their resistance to C. immitis.
has been maintained since then by H. Walch (San Diego State University, San Diego, Calif.) who kindly gave us the R.S. strain and a-mutant of this strain, denoted 95-271. This mutant is auxotrophic for paraaminobenzoic acid and riboflavin. It is also temperature sensitive, being unable to grow only at temperatures less than 37°C, and nonpathogenic for mice (21) . We maintained both strains in their mycelial form at 25°C on Mycophil agar (BBL Microbiology Systems, Cockeysville, Md.). The spherule form of C. immitis 95-271 was grown at 31°C on Brosbe's modification of Converse medium (4) in an atmosphere of 5% O,-10o C02-85% N2. At each passage, endospores were enriched by the method of Levine et al. (13) , and, after five passages, all growth was in the spherule form.
Mycelia were harvested by flooding the surface of the agar with distilled water and gently scraping the surface. Arthroconidia were liberated from mycelia by vortexing the suspension with 5-mm glass beads and washing three times by centrifugation at 500 x g at 4°C. Formalin-fixed spherules and arthroconidia were prepared by treatment with 0.5% Formalin (Mallincrodt Inc., St. Louis, Mo.) in phosphate-buffered saline at 4°C for 3 days, followed by extensive washing.
Infection model. Age-matched female mice, 2 to 5 months of age, were inoculated intraperitoneally with a suspension of arthroconidia in 0.145 M saline. The number of organisms was estimated by counting in a hemacytometer and confirmed by colony counts. The mice were housed in a Germfree isolator (Germfree Laboratories, Inc., Miami, Fla.) for the duration of the experiment. The mean lethal dose (LD50) values were calculated by probit transformation (8), using mortality rates obtained with at least four different doses of arthroconidia and groups of 5 to 10 mice per dose. To estimate the number of viable C. immitis in the organs, groups of mice were infected intraperitoneally with 5 x 102 R.S. arthroconidia. On the day of sacrifice, organs were removed, homogenized in 1% Triton X-100 in water, diluted in water, and plated on Mycosel agar containing 50 ,ug of gentamicin per ml. The number of colonies was counted after 3 days of incubation at 25°C. We did not do colony counts on the organs of mice that died before the scheduled day of sacrifice. In some cases, tissues for biopsy were taken from intraabdominal organs and lungs at the time of sacrifice for histological examination.
In vitro proliferation assay. A modification of the method developed by Corridin et al. was used for the in vitro proliferation assay (6) . Mice were immunized in the hind footpads and base of the tail with 1.5 x 106 Formalin-treated 95-271 spherules in complete Freund adjuvant (H37Ra) (Difco Laboratories, Detroit, Mich.). After 10 to 17 days, the inguinal and paraaortic lymph nodes were removed and teased into single cell suspensions. Enrichment for T lymphocytes was accomplished by nylon wool passage (12) . Nylon woolpurified T cells were plated at 1. 
RESULTS
Susceptibility of inbred mouse strains to intraperitoneal C. immitis infection. When mice were inoculated intraperitoneally with a suspension of arthroconidia, deaths began to occur 10 days after infection, and survival time was inversely related to the infecting dose. Over the range of 102 to 106 organisms per infecting dose, most deaths occurred within 28 days after infection. Therefore, this time period was chosen to determine cumulative mortality.
Initially, we compared the LD50 in BALB/C and DBA/2N mice, two inbred strains that have in common the H-2d haplotype. We discovered that the LD50 for DBA/2N mice was 1,000 times higher than the LD50 for BALB/cAnN mice (Fig.  1 ). These observations strongly suggested that there was a genetic basis for resistance to C. immitis in mice, but that resistance was not (Fig. 2) . By day 7, C. immitis was recovered from the omental tissue of both strains of mice, and neither the percentage of infected mice nor the mean number of CFU was significantly different in the two strains. However, by day 10 there were more fungi in the omenta and spleens of BALB/cAnN The most striking difference between the two strains was that BALB/cAnN mice developed pneumonia and DBA/2N mice did not. In fact, we recovered C. immitis from the lungs of only one of five mice on days 14 and 19, whereas on those days all the BALB/cAnN mice had pneumonia which was extensive enough to explain their high mortality.
Histological studies were done on the organs of both mouse strains as well. There were no qualitative differences in the pathology of BALB/cAnN and DBA/2N mice. Mice of both strains formed granuloma in response to the infection; the number of granuloma correlated with the number of CFU. Response of BALB/c mice to immunization. Since it appeared that infected BALB/cAnN mice did not mount an effective immune response during infection, we examined their ability to respond to immunization with C. immitis.
Mice were immunized subcutaneously with 105 viable arthroconidia of the attenuated mutant, strain 95-271. Vaccination with this mutant strain has been reported to protect outbred mice from an otherwise lethal inoculum of C. immitis (21) . BALB/cAnN mice were also protected by vaccination (Table 2 ). Since T lymphocytes confer resistance to C. immitis (1), the ability to immunize BALB/cAnN mice suggests that their T lymphocytes respond to C. immitis antigens and that the effector arm of their immune response is intact.
Response BALB/cAnN mice. Resistance was shown to be the dominate phenotype. We also found that, despite their marked susceptibility to fatal infections, BALB/cAnN mice could be successfully immunized with C. immitis; after immunization, their T cells responded to coccidiodal antigen in vitro, and the mice were completely protected from an otherwise lethal infection. These observations suggested that the increased susceptibility of BALB/cAnN mice was not due to an absolute inability of their T cells to respond to C. immitis nor to an absolute defect in effector cell (macrophage) function. However, the fact that C. immitis produces a progressive local infection that dissemninates and kills BALB/cAnN mice in less than 4 weeks suggests that these mice do not mount an effective immune response during infection, even though they can respond to spherule antigens when presented either in the form of a killed vaccine or as spherules produced in vivo after immunization with aolive vaccine. Since the severity of the initial stage of infection (through day 10) was nearly identical in DBAI2N and BALB/cAnN mice, the resistance of DBA/2N mice was not due to their unique ability to prevent germination of the arthroconidia to spherules or to prevent multiplication of spherules during the time before specific immunity had developed.
Although we tested only five mouse strains, we know that the distribution of susceptible and resistant strains does not correspond to the strain distribution resistance to Leishmania tropica (10), Listeria monocytogenes (5), Blastomyces dermatitidis (15) , or Cryptococcus neo- Even though the mice were not infected by the respiratory route, our model of coccidioidomycosis has several parallels with the human disease. In both cases, resistance is related to the ability of the host to confine the infection to the portal of entry, and lethal infections are the result of progressive dissemination. Both susceptible and resistant mice responded to the fungus with granuloma, indistinguishable from the human response. Considering these parallels, we are hopeful that what we learn about natural resistance to C. immitis peritonitis in the mouse may be applicable to human coccidioidomycosis.
